Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Andrew Meltzer

Emergency Medicine Washington, DC Medical Doctor

NPI 1366478505 CMS profile 487809

2150 Pennsylvania Avenue Nw, Suite 2B, Washington, DC 20037

Open in the dashboard

General payments

$113,934

58 records reported · program years 2021–2025

Research payments

$64,759

Paid to them · 6 records reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,358,250 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Andrew Meltzer of Washington, DC is reported in the CMS Open Payments database as having received $113,934 across 58 general payments and $64,759 in research payments paid to them. Separately, studies naming them as principal investigator received $1,358,250 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $58,206 22
2024 General $12,223 8
2023 General $41,820 22
2023 Research $53,085 1
2022 General $184 2
2022 Research $11,674 5
2021 General $1,501 4

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Meltzer
  • Emergency Medicine median
  • Middle half of Emergency Medicine
  • National median

In program year 2025, general payments to Andrew Meltzer were reported at $58,206. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.

Show as a table
Year Andrew Meltzer Emergency Medicine median Middle half National median
2019 $0 $51 $18–$128 $163
2020 $0 $29 $16–$99 $114
2021 $1,501 $40 $18–$124 $132
2022 $184 $49 $20–$134 $149
2023 $41,820 $51 $22–$142 $160
2024 $12,223 $52 $22–$150 $164
2025 $58,206 $57 $24–$150 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. bioMerieux $50,778 21 payments
  2. Gilead Sciences, Inc. $41,692 7 payments
  3. BioFire Diagnostics, LLC $16,781 18 payments
  4. Vapotherm Inc $4,364 6 payments
  5. MeMed US, Inc. $178 1 payment
  6. W. L. Gore & Associates, Inc. $74 2 payments
  7. AstraZeneca Pharmaceuticals LP $43 2 payments
  8. Bavarian Nordic A/S $24 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Consulting Fee $70,417 17 payments
  2. Travel and Lodging $32,550 12 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,659 5 payments
  4. Food and Beverage $1,129 23 payments
  5. Gift $178 1 payment
Products named General payments · program years 2021–2025
  1. BIOFIRE SPOTFIRE Respiratory/Sore Throat (R/ST) Panel $16,323 8 payments
  2. BIOFIRE RESPIRATORY PANEL 2.1 $6,665 13 payments
  3. BioFire Joint Infection (JI) Panel $3,335 1 payment
  4. Vapotherm Respiratory $2,838 2 payments
  5. VAPOTHERM Respiratory $1,526 4 payments
  6. MeMed BV $178 1 payment
  7. FilmArray 2.0 Instrument $156 1 payment
  8. Product in Development $74 2 payments
  9. Encepur $24 1 payment
  10. LOKELMA $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. BioFire Diagnostics, LLC $53,085 1 payment
  2. bioMerieux $11,674 5 payments

Billing to Medicare

Part B · data year 2024 · 12 billing codes

Paid by Medicare

$11,114

Medicare's payments for the services billed

Medicare patients

101

Average age 65

Services billed

115

57 women, 44 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 52%
Diabetes 51%
Ischemic heart disease 38%
Chronic kidney disease 36%
Depression 35%
Heart failure 33%
COPD 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

64 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Emergency Medicine in District of Columbia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record